Virulence potential and adherence properties of Escherichia coli that produce CTX-M and NDM β-lactamases

Journal of Medical Microbiology

Volumn 62, Issue PART4, 2013, Pages 525-530

  Peirano, Gisele ^a,b   Mulvey, George L ^b   Armstrong, Glen D ^b   Pitout, Johann D D ^a,b  

^a CALGARY LABORATORY SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL STRAIN CACO 2; CELL STRAIN HEPG2; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL;

BACTERIAL ADHESION; BETA-LACTAMASES; CELL LINE; EPITHELIAL CELLS; ESCHERICHIA COLI; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; VIRULENCE; VIRULENCE FACTORS;

EID: 84875180450     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.048983-0     Document Type: Article

References (35)

1. CLSI (2012). Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
2. Coelho, A., Mora, A., Mamani, R., López, C., González-López, J. J., Larrosa, M. N., Quintero-Zarate, J. N., Dahbi, G., Herrera, A. & other authors (2011). Spread of Escherichia coli O25b: H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother 66, 517-526.
3. Coque, T. M., Novais, A., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R. & Nordmann, P. (2008). Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 14, 195-200.
4. Dobrindt, U. (2005). (Patho-)genomics of Escherichia coli. Int J Med Microbiol 295, 357-371.
5. Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Hsueh, P. R. & Paterson, D. L. (2009). Emergence of high levels of extendedspectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 53, 3280-3284.
6. Hyland, R. M., Griener, T. P., Mulvey, G. L., Kitov, P. I., Srivastava, O. P., Marcato, P. & Armstrong, G. D. (2006). Basis for Nacetyllactosamine-mediated inhibition of enteropathogenic Escherichia coli localized adherence. J Med Microbiol 55, 669-675.
7. Hyland, R. M., Sun, J., Griener, T. P., Mulvey, G. L., Klassen, J. S., Donnenberg, M. S. & Armstrong, G. D. (2008). The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin. Cell Microbiol 10, 177-187.
8. Johnson, J. R. & Stell, A. L. (2000). Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181, 261-272.
9. Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K. & Zhanel, G. G. (2009). Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53, 2733-2739.
10. Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A. & Castanheira, M. (2010). Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51, 286-294.
11. Jones, G. L., Warren, R. E., Skidmore, S. J., Davies, V. A., Gibreel, T. & Upton, M. (2008). Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases. J Antimicrob Chemother 62, 1245-1251.
12. Laupland, K. B., Church, D. L., Vidakovich, J., Mucenski, M. & Pitout, J. D. (2008). Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 57, 441-448.
13. Mihaila, L., Wyplosz, B., Clermont, O., Garry, L., Hipeaux, M. C., Vittecoq, D., Dussaix, E., Denamur, E. & Branger, C. (2010). Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone. J Antimicrob Chemother 65, 1537-1539.
14. Mora, A., Blanco, M., López, C., Mamani, R., Blanco, J. E., Alonso, M. P., García-Garrote, F., Dahbi, G., Herrera, A. & other authors (2011). Emergence of clonal groups O1:HNM-D-ST59, O15:H1-DST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21, 42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 37, 16-21.
15. Mushtaq, S., Irfan, S., Sarma, J. B., Doumith, M., Pike, R., Pitout, J., Livermore, D. M. & Woodford, N. (2011). Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother 66, 2002-2005.
16. Nordmann, P., Poirel, L., Walsh, T. R. & Livermore, D. M. (2011). The emerging NDM carbapenemases. Trends Microbiol 19, 588-595.
17. Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D. & Hooper, D. C. (2006). Prevalence in the United States of aac(69)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50, 3953-3955.
18. Peirano, G. & Pitout, J. D. (2010). Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35, 316-321.
19. Peirano, G., Ahmed-Bentley, J., Woodford, N. & Pitout, J. D. (2011a). New Delhi metallo-beta-lactamase from traveler returning to Canada. Emerg Infect Dis 17, 242-244.
20. Peirano, G., Schreckenberger, P. C. & Pitout, J. D. (2011b). Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother 55, 2986-2988.
21. Peirano, G., van der Bij, A. K., Gregson, D. B. & Pitout, J. D. (2012). Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum b-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J Clin Microbiol 50, 294-299.
22. Pitout, J. D. (2012). Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 3, 9.
23. Pitout, J. D. & Laupland, K. B. (2008). Extended-spectrum betalactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8, 159-166.
24. Pitout, J. D., Nordmann, P., Laupland, K. B. & Poirel, L. (2005). Emergence of Enterobacteriaceae producing extended-spectrum betalactamases (ESBLs) in the community. J Antimicrob Chemother 56, 52-59.
25. Pitout, J. D., Church, D. L., Gregson, D. B., Chow, B. L., McCracken, M., Mulvey, M. R. & Laupland, K. B. (2007). Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates. Antimicrob Agents Chemother 51, 1281-1286.
26. Pitout, J. D., Campbell, L., Church, D. L., Gregson, D. B. & Laupland, K. B. (2009). Molecular characteristics of travel-related extendedspectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrob Agents Chemother 53, 2539-2543.
27. Poirel, L., Lagrutta, E., Taylor, P., Pham, J. & Nordmann, P. (2010). Emergence of metallo-b-lactamase NDM-1-producing multidrugresistant Escherichia coli in Australia. Antimicrob Agents Chemother 54, 4914-4916.
28. Robicsek, A., Strahilevitz, J., Sahm, D. F., Jacoby, G. A. & Hooper, D. C. (2006). qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50, 2872-2874.
29. Russo, T. A. & Johnson, J. R. (2003). Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5, 449-456.
30. Smet, A., Martel, A., Persoons, D., Dewulf, J., Heyndrickx, M., Claeys, G., Lontie, M., Van Meensel, B., Herman, L. & other authors (2010). Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 16, 129-134.
31. Sullivan, C. B., Diggle, M. A. & Clarke, S. C. (2005). Multilocus sequence typing: data analysis in clinical microbiology and public health. Mol Biotechnol 29, 245-254.
32. van der Bij, A. K. & Pitout, J. D. (2012). The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 67, 2090-2100.
33. Van der Bij, A. K., Peirano, G., Pitondo-Silva, A. & Pitout, J. D. (2012). The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. Diagn Microbiol Infect Dis 72, 297-302.
34. Yamane, K., Wachino, J., Suzuki, S. & Arakawa, Y. (2008). Plasmidmediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 52, 1564-1566.
35. Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K. & Walsh, T. R. (2009). Characterization of a new metallo-betalactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53, 5046-5054.